The cluster is large in absolute dollars but trivial relative to market cap. The C-suite breadth (CFO, CLO, CIO, two segment CEOs) is unusual and may reflect a coordinated post-earnings diversification window rather than a bearish signal, especially given the strong Q4 results and raised guidance. Monitor for any follow-on sales in the next 30 days—if these are one-time events, the signal is noise; if they continue, it would be more concerning. The $5.0B buyback provides a natural offset to any selling pressure.
Price Chart
Executive Summary
A cluster of insider sales at Cardinal Health occurred 9 days after the company reported strong Q4 FY2026 earnings (revenue $63.7B, +6% YoY; non-GAAP EPS $2.91, +40% YoY) and announced a $5.0B buyback authorization. The cluster includes CFO Aaron Alt, the Chief Legal Officer, the CIO, and two segment CEOs, with total open-market sales of approximately $29.0M. While the dollar amount is only ~0.05% of the $54.6B market cap (trivial by proportionality), the breadth of C-suite participation—especially the CFO selling $9.9M—warrants attention. The sales are likely liquidity-driven following a strong earnings-driven stock rally, but the cluster's composition prevents a purely dismissive read.
Key Financial Metrics
Key Facts
- Total open-market insider sales of ~$29.0M across 19 trades on August 18, 2026
- CFO Aaron Alt sold $9.9M (13,685 + 12,972 + 12,228 + 3,115 shares)
- Chief Legal Officer Jessica Mayer sold $6.0M (10,864 + 4,426 + 10,246 + 3,900 shares)
- CIO Michelle Greene sold $2.7M (686 + 3,512 + 4,952 + 2,500 shares)
- Segment CEOs: Mason (GMPD) sold $8.3M, Weitzman (PSS) sold $1.7M
- One tax-withholding event (Mayer, 25,285 shares, $5.9M) is non-cash and excluded from open-market total
- Sales occurred 9 days after Q4 FY2026 earnings beat and $5.0B buyback announcement
- Total open-market sales represent ~0.05% of $54.6B market cap—trivial by proportionality
- Stock price on sale dates: $234.55–$237.44, near post-earnings highs
Financial Impact
Open-market insider sales of ~$29.0M, representing 0.05% of market cap
Risk Factors
- CFO selling $9.9M near highs could signal peak valuation concerns despite strong earnings
- Broad C-suite participation (5 officers) reduces likelihood of purely idiosyncratic liquidity needs
- If sales continue in subsequent weeks, the cluster becomes more informative per insider-selling literature
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CAH-1787225556956 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 20, 2026 6w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $230.09 (+0.71%) |
Aug 20, 2026 6w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $230.09 (+0.71%) |
Aug 20, 2026 6w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $230.09 (+0.71%) |
Aug 11, 2026 7w ago | 8-K | $240.26 $239.92 | ▼ −0.14% | ▲ +0.92% | $230.09 (−4.23%) |
Aug 11, 2026 7w ago | 8-K | $240.26 $239.92 | ▼ −0.14% | ▲ +0.92% | $230.09 (−4.23%) |
Aug 5, 2026 8w ago | 8-K | $239.23 $245.49 | ▲ +2.62% | ▲ +3.22% | $230.09 (−3.82%) |
Jul 20, 2026 10w ago | Press Release | $227.09 $234.98 | ▲ +3.47% | ▲ +0.91% | $230.09 (+1.32%) |
Mar 5, 2026 30w ago | 8-K | $215.96 $214.02 | ▼ −0.90% | ▲ +2.89% | $230.09 (+6.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access